Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics Plc ADR (NQ: AUTL )

6.200 USD -0.210 (-3.28%)
Official Closing Price Updated: 7:55 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,301,600
Open 6.400
Bid (Size) 6.110 (1)
Ask (Size) 6.340 (10)
Prev. Close 6.410
Today's Range 5.830 - 6.670
52wk Range 3.000 - 17.19
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
Conference call to be held on March 4, 2021 at 8:30 am ET/1:30 pm GMT 
From GlobeNewswire News Releases
Autolus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases

Performance

YTD
-33.76%
-33.76%
1 Month
-18.64%
-18.64%
3 Month
-41.29%
-41.29%
6 Month
-51.75%
-51.75%
1 Year
-33.26%
-33.26%

More News

Read More
Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs
From GlobeNewswire News Releases
Autolus Announces Pricing of Public Offering
From GlobeNewswire News Releases
Autolus Announces Proposed Public Offering in the United States
From GlobeNewswire News Releases
Autolus Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 4
From GlobeNewswire News Releases
Autolus Therapeutics provides business outlook for 2021 & 2022
From GlobeNewswire News Releases
Autolus Therapeutics to participate in Investor Conferences through January
From GlobeNewswire News Releases
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the 62nd ASH Annual Meeting
From GlobeNewswire News Releases
Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting
From GlobeNewswire News Releases
Autolus Therapeutics's Earnings: A Preview
Tags Market News Benzinga BZI/EP
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.